Share:
Esperion Therapeutics (NASDAQ: ESPR) shares are trading higher on Wednesday after the company announced Swiss Approval for the first-in-class cholesterol-lowering treatment NILEMDO and its Combination with NUSTENDI.
Esprit Holdings is an international fashion brand whose operations include Retail, Wholesale and Licensing. It produces garments that are sold at its directly managed retail outlets.
Esperion Therapeutics shares were trading down 1.77% at $27.67. The stock has a 52-week high of $76.98 and a 52-week low of $23.90.
Anika Therapeutics (NASDAQ: ANIK) shares are trading higher after Barrington Research upgraded the stock from Market Perform to Outperform and announced a price target of $43 per share.